198 related articles for article (PubMed ID: 22190576)
1. Cellular MRI as a suitable, sensitive non-invasive modality for correlating in vivo migratory efficiencies of different dendritic cell populations with subsequent immunological outcomes.
de Chickera S; Willert C; Mallet C; Foley R; Foster P; Dekaban GA
Int Immunol; 2012 Jan; 24(1):29-41. PubMed ID: 22190576
[TBL] [Abstract][Full Text] [Related]
2. Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging.
Dekaban GA; Hamilton AM; Fink CA; Au B; de Chickera SN; Ribot EJ; Foster PJ
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):469-83. PubMed ID: 23633389
[TBL] [Abstract][Full Text] [Related]
3. Detection of prostaglandin E2-induced dendritic cell migration into the lymph nodes of mice using a 1.5 T clinical MR scanner.
Joo HJ; Kim HS; Choi YS; Kim H; Kim SJ; Moon WK
NMR Biomed; 2012 Apr; 25(4):570-9. PubMed ID: 22009917
[TBL] [Abstract][Full Text] [Related]
4. Ethanol affects the generation, cosignaling molecule expression, and function of plasmacytoid and myeloid dendritic cell subsets in vitro and in vivo.
Lau AH; Abe M; Thomson AW
J Leukoc Biol; 2006 May; 79(5):941-53. PubMed ID: 16478920
[TBL] [Abstract][Full Text] [Related]
5. In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice.
Baumjohann D; Hess A; Budinsky L; Brune K; Schuler G; Lutz MB
Eur J Immunol; 2006 Sep; 36(9):2544-55. PubMed ID: 16909432
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant effect of a natural TLR4 ligand on dendritic cell-based cancer immunotherapy.
Kim JY; Kim YJ; Kim JS; Ryu HS; Lee HK; Kang JS; Kim HM; Hong JT; Kim Y; Han SB
Cancer Lett; 2011 Dec; 313(2):226-34. PubMed ID: 21974804
[TBL] [Abstract][Full Text] [Related]
7. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
[TBL] [Abstract][Full Text] [Related]
8. Multimodal imaging of nanovaccine carriers targeted to human dendritic cells.
Cruz LJ; Tacken PJ; Bonetto F; Buschow SI; Croes HJ; Wijers M; de Vries IJ; Figdor CG
Mol Pharm; 2011 Apr; 8(2):520-31. PubMed ID: 21381651
[TBL] [Abstract][Full Text] [Related]
9. Enhanced efficacy of therapeutic cancer vaccines produced by co-treatment with Mycobacterium tuberculosis heparin-binding hemagglutinin, a novel TLR4 agonist.
Jung ID; Jeong SK; Lee CM; Noh KT; Heo DR; Shin YK; Yun CH; Koh WJ; Akira S; Whang J; Kim HJ; Park WS; Shin SJ; Park YM
Cancer Res; 2011 Apr; 71(8):2858-70. PubMed ID: 21368092
[TBL] [Abstract][Full Text] [Related]
10. Two-step maturation of immature DCs with proinflammatory cytokine cocktail and poly(I:C) enhances migratory and T cell stimulatory capacity.
Kim HJ; Kim HO; Lee K; Baek EJ; Kim HS
Vaccine; 2010 Apr; 28(16):2877-86. PubMed ID: 20156531
[TBL] [Abstract][Full Text] [Related]
11. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage.
Labeur MS; Roters B; Pers B; Mehling A; Luger TA; Schwarz T; Grabbe S
J Immunol; 1999 Jan; 162(1):168-75. PubMed ID: 9886383
[TBL] [Abstract][Full Text] [Related]
12. Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma model.
Pilon-Thomas S; Li W; Briggs JJ; Djeu J; Mulé JJ; Riker AI
J Immunother; 2006; 29(4):381-7. PubMed ID: 16799333
[TBL] [Abstract][Full Text] [Related]
13. Fusion of CpG-ODN-stimulating dendritic cells with Lewis lung cancer cells can enhance anti-tumor immune responses.
Du YC; Lin P; Zhang J; Lu YR; Ning QZ; Wang Q
Tissue Antigens; 2006 May; 67(5):368-76. PubMed ID: 16671943
[TBL] [Abstract][Full Text] [Related]
14. Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine.
den Brok MH; Sutmuller RP; Nierkens S; Bennink EJ; Toonen LW; Figdor CG; Ruers TJ; Adema GJ
Cancer Res; 2006 Jul; 66(14):7285-92. PubMed ID: 16849578
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell maturation with poly(I:C)-based versus PGE2-based cytokine combinations results in differential functional characteristics relevant to clinical application.
Möller I; Michel K; Frech N; Burger M; Pfeifer D; Frommolt P; Veelken H; Thomas-Kaskel AK
J Immunother; 2008 Jun; 31(5):506-19. PubMed ID: 18463533
[TBL] [Abstract][Full Text] [Related]
16. Labelling dendritic cells with SPIO has implications for their subsequent in vivo migration as assessed with cellular MRI.
de Chickera SN; Snir J; Willert C; Rohani R; Foley R; Foster PJ; Dekaban GA
Contrast Media Mol Imaging; 2011; 6(4):314-27. PubMed ID: 21861291
[TBL] [Abstract][Full Text] [Related]
17. Cupressaceae pollen grains modulate dendritic cell response and exhibit IgE-inducing adjuvant activity in vivo.
Kamijo S; Takai T; Kuhara T; Tokura T; Ushio H; Ota M; Harada N; Ogawa H; Okumura K
J Immunol; 2009 Nov; 183(10):6087-94. PubMed ID: 19864594
[TBL] [Abstract][Full Text] [Related]
18. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17.
Fransen JH; Hilbrands LB; Ruben J; Stoffels M; Adema GJ; van der Vlag J; Berden JH
Arthritis Rheum; 2009 Aug; 60(8):2304-13. PubMed ID: 19644874
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
Liu Y; Huang H; Chen Z; Zong L; Xiang J
J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
[TBL] [Abstract][Full Text] [Related]
20. CpG-DNA aided cross-presentation of soluble antigens by dendritic cells.
Maurer T; Heit A; Hochrein H; Ampenberger F; O'Keeffe M; Bauer S; Lipford GB; Vabulas RM; Wagner H
Eur J Immunol; 2002 Aug; 32(8):2356-64. PubMed ID: 12209649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
